References
- Haddad PM, Hellewell JS, Wieck A. Antipsychotic induced hyperprolactinemia: a series of illustrative case reports. J Pharmacol 2001; 15: 293–295
- Haddad PM, Wieck A. Antipsychotic-induced hyperprolactinaemia: mechanisms, clinical features and management. Drugs 2004; 64: 2291–2314
- Szarfman A, Tonning JM, Levine JG, Doraiswamy PM. Atypical antipsychotics and pituitary tumors: a pharmacovigilance study. Pharmacotherapy 2006; 26: 748–758
- Koves IH, Jarman FC, Cameron FJ. Antipsychotic medication and marked hyperprolactinaemia: iatros or true prolactinoma?. Acta Paediatr 2004; 93: 1543–1547
- Chapman S. Questionable inflated estimate of smoking prevalence among mentally ill persons in Australia. Aust N Z J Psychiatry 2008; 42: 646–648
- Australian Bureau of Statistics. National health survey. Summary of results, 2004–05. ABS Cat. 4364.0. Canberra: Australian Bureau of Statistics, 2006.
- Australian Bureau of Statistics. Mental health and wellbeing: profile of adults, Australia, 1997. ABS Cat. 4326.0. Canberra: Australian Bureau of Statistics, 1998.
- Australian Bureau of Statistics. National Survey of Mental Health and Wellbeing: Summary of Results, 2007. ABS Cat 4326.0. Canberra: Australian Bureau of Statistics, 2008.
- Lasser K, Boyd JW, Woolhandler S, Himmelstein DU, McCormick D, Bor DH. Smoking and mental illness. A population-based prevalence study. JAMA 2000; 284: 2606–2610
- National Preventative Health Taskforce. Technical report No 2. Tobacco control in Australia: making smoking history. Canberra: Commonwealth of Australia, 2008.
- Köhler C, Ogren SO, Fuxe K. Studies on the mechanism of action of substituted benzamide drugs. Acta Psychiatr Scand Suppl 1984; 311: 125–137
- Mucci A, Nolfe G, Maj M. Levosulpiride: a review of its clinical use in psychiatry. Pharmacol Res 1995; 31: 95–101
- Baik JS, Lyoo CH, Lee JH, Lee MS. Drug-induced and psychogenic resting suprahyoid neck and tongue tremors. Mov Disord 2008; 23: 746–748
- Das KB, Harris C, Smyth DP, Cross JH. Unusual side effects of lamotrigine therapy. J Child Neurol 2003; 18: 479–480
- Parker G. How should mood disorders be modelled?. Aust N Z J Psychiatry 2008; 42: 841–850
- Joyce PR. Classification of mood disorders in DSM-V and DSM-VI. Aust N Z J Psychiatry 2008; 42: 851–862
- Horwitz AV, Wakefield JC. The loss of sadness: how psychiatry transformed normal sorrow into depressive disorder. Oxford, New York 2007
- McLaren N. Humanizing madness: psychiatry and the cognitive neurosciences. Future Psychiatry Press, Ann Arbor, MI 2007
- McLaren N. Kandel's ‘new science of mind’ for psychiatry and the limits to biological reductionism: a critical review. Ethic Hum Psychol Psychiatry 2008; 10: 109–121